You have 2 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

locally advanced pancreatic cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Pancreatic Cancer Trial (FOLFIRINOX treatment)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • FOLFIRINOX treatment
  • (no location specified)
Aug 9, 2023

Pancreatic Carcinoma Trial in Shanghai (carbon ion radiotherapy)

Recruiting
  • Pancreatic Carcinoma
  • carbon ion radiotherapy
  • Shanghai, Shanghai, China
    Shanghai Proton and Heavy Ion Center
Nov 21, 2021

Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Trial in

Completed
  • Borderline Resectable Pancreatic Adenocarcinoma
  • +6 more
  • Houston, Texas
  • +4 more
Aug 31, 2022

Pancreatic Ductal Adenocarcinoma, Pancreas Adenocarcinoma, Pancreas Cancer Trial in Kansas City (Enfortumab vedotin)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Enfortumab vedotin
  • Kansas City, Kansas
    University of Kansas Cancer Center
Jun 23, 2023

Borderline Resectable Pancreatic Cancer, Locally Advanced Pancreatic Adenocarcinoma Trial in Shanghai (Nab paclitaxel plus

Recruiting
  • Borderline Resectable Pancreatic Cancer
  • Locally Advanced Pancreatic Adenocarcinoma
  • Shanghai, Shanghai, China
    Department of Pancreatic Surgery, Fudan University Shanghai Canc
Jan 27, 2022

Quality of Life, Locally Advanced Pancreatic Carcinoma, Metastatic Pancreatic Cancer Trial (ARACOMPLEX®, )

Not yet recruiting
  • Quality of Life
  • +2 more
  • ARACOMPLEX®
  • placebo
  • (no location specified)
Nov 28, 2022

Ductal Adenocarcinoma of the Pancreas Trial in Würzburg (Gem/nab-Pac, FOLFIFINOX)

Completed
  • Ductal Adenocarcinoma of the Pancreas
  • Würzburg, Bayern, Germany
    Universitätsklinikum Würzburg/Comprehensive Cancer Center Mainfr
Dec 14, 2021

Locally Advanced Pancreatic Cancer, Irreversible Electroporation Trial (Irreversible electroporation (NanoKnife® ))

Not yet recruiting
  • Locally Advanced Pancreatic Cancer
  • Irreversible Electroporation
  • Irreversible electroporation (NanoKnife® )
  • (no location specified)
Sep 27, 2021

Locally Advanced Pancreatic Adenocarcinoma Trial in Houston (SD-101, pebrolizumab)

Recruiting
  • Locally Advanced Pancreatic Adenocarcinoma
  • Houston, Texas
    MD Anderson Cancer Center
Nov 18, 2022

Pancreas Cancer Trial in Halle (Saale) (Visceral Debranching)

Recruiting
  • Pancreas Cancer
  • Visceral Debranching
  • Halle (Saale), Germany
    University Hospital, Dpt. of Visceral, Vascular and Endocrine Su
Sep 27, 2021

Pancreatic Cancer Trial in Tianjin (surufatinib + gemcitabine + nab-paclitaxel)

Recruiting
  • Pancreatic Cancer
  • surufatinib + gemcitabine + nab-paclitaxel
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Jun 15, 2023

Pancreatic Cancer Trial in United States (Hypofractionated ablative IMRT (HFA-IMRT), capecitabine)

Active, not recruiting
  • Pancreatic Cancer
  • Basking Ridge, New Jersey
  • +7 more
May 4, 2022

Pancreatic Cancer Trial in Rozzano (SBRT and chemo)

Completed
  • Pancreatic Cancer
  • SBRT and chemotherapy
  • Rozzano, Milan, Italy
    Humanitas Research Hospital
Sep 14, 2022

Pancreas Cancer, Locally Advanced, Locally Advanced Pancreatic Adenocarcinoma Trial in Miami (Stereotactic Ablative Body

Not yet recruiting
  • Pancreas Cancer
  • +2 more
  • Stereotactic Ablative Body Radiation (SABR)
  • Tumor Treating Fields (TTF)
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Dec 27, 2022

Unresectable Locally Advanced or Metastatic Pancreatic Cancer Trial in Shanghai (surufatinib, KN046, gemcitabine)

Not yet recruiting
  • Unresectable Locally Advanced or Metastatic Pancreatic Cancer
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Apr 16, 2023

Locally Advanced Pancreatic Adenocarcinoma Trial in France (Gabrinox, MRI-GUIDED STEREOTACTIC RADIOTHERAPY)

Recruiting
  • Locally Advanced Pancreatic Adenocarcinoma
  • Gabrinox
  • MRI-GUIDED STEREOTACTIC RADIOTHERAPY
  • Dijon, Côte d'Or, France
  • +4 more
Jan 2, 2022

Locally Advanced Unresectable Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8

Recruiting
  • Locally Advanced Pancreatic Carcinoma
  • +3 more
  • Biopsy
  • +5 more
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center EDDOP
Nov 30, 2022

Locally Advanced Pancreatic Cancer (LAPC) Trial in Herlev (Gemcitabine, Nab-paclitaxel, Nivolumab)

Recruiting
  • Borderline Resectable, Locally Advanced or Metastatic Pancreatic Cancer
  • Herlev, Denmark
    Herlev & Gentofte University Hospital, Denmark
Oct 13, 2022

Pancreatic Cancer Trial in Loma Linda (Proton, Gemcitabine, Erlotinib, Capecitabine, Proton Radiation)

Terminated
Has Results
  • Pancreatic Cancer
  • Proton, Gemcitabine, Erlotinib, Capecitabine
  • Proton Radiation
  • Loma Linda, California
    Loma Linda University Medical Center
Aug 7, 2021

Pancreatic Cancer Trial in United States (Stereotactic Body Radiotherapy (SBRT))

Active, not recruiting
  • Pancreatic Cancer
  • Stereotactic Body Radiotherapy (SBRT)
  • Basking Ridge, New Jersey
  • +6 more
Feb 11, 2022

Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal

Recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • +3 more
  • Hafnium Oxide-containing Nanoparticles NBTXR3
  • Radiation Therapy
  • Houston, Texas
    M D Anderson Cancer Center
Jun 15, 2022

Pancreatic Cancer Trial in Aurora (FOLFIRINOX or gemcitabine/abraxane, SBRT)

Active, not recruiting
  • Pancreatic Cancer
  • FOLFIRINOX or gemcitabine/abraxane
  • SBRT
  • Aurora, Colorado
    University of Colorado
Jul 22, 2021

Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in

Recruiting
  • Advanced Pancreatic Carcinoma
  • +27 more
  • Gainesville, Florida
  • +3 more
Jan 3, 2023

Pancreatic Tumors Trial in Guangzhou (Surufatinib, Sintilimab, AG)

Not yet recruiting
  • Pancreatic Neoplasms
  • Guangzhou, Guangdong, China
    Cancer center of SunYat-sen University
Jul 28, 2022

Pancreatic Cancer Non-resectable Trial in Shanghai (Carbon ion radiotherapy)

Not yet recruiting
  • Pancreatic Cancer Non-resectable
  • Carbon ion radiotherapy
  • Shanghai, China
    Shanghai Proton and Heavy Ion Center
Jun 22, 2022